NAFDAC Grants License for the importing of the proprietary patented therapy LodonalTM as an adjunct treatment for HIV/AIDS and opportunistic infections. ORLANDO, Fla. and DUBLIN, Ireland, Aug. 10, 2015 (GLOBE NEWSWIRE) -- via PRWEB - "We are pleased to receive the import license for LodonalTM in Nigeria," said Noreen Griffin Immune Therapeutics' Chief...

Immune Therapeutics Inc. in partnership with GB Pharma and AHAR sign LOI with Fidson Healthcare Plc for the distribution of Lodonal in Nigeria. ORLANDO, Florida and Dublin, Aug. 3, 2015 (GLOBE NEWSWIRE) -- via PRWEB - An agreement between Immune Therapeutics GB Pharma/AHAR with Fidson Healthcare will enable Fidson marketing, sales, customer...